Biogen (BIIB) shares recorded their fifth consecutive day of increases, accumulating a total return of 14% during this span. The company’s market value has increased by approximately $3.3 billion over ...

Biogen has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.7%. The stock now ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Markets are tanking on tariff fears, inflationary ...

We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. On December 10, TheFly reported that HSBC downgraded BIIB from Hold to Reduce, and lowered its price target to $143, ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available this week, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Biogen Inc. (BIIB) reports results for the ...

Biogen Inc (NASDAQ:BIIB) reflects mixed sentiment as Nasdaq composite trends highlight biotech sector dynamics.

Markets are tanking on tariff fears, inflationary concerns and now fears of recession. "Given this is so uncertain and that there are new announcements every hour or so, it’s kind of unclear what the ...